Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.05 BRL
−739.77 M BRL
27.38 B BRL
4.75 B
About HAPVIDA ON NM
Sector
Industry
CEO
Jorge F. Pinheiro Koren de Lima
Website
Headquarters
Fortaleza
Founded
1979
ISIN
BRHAPVACNOR4
FIGI
BBG00K8GZYJ8
Hapvida Participações e Investimentos SA operates hospitals and clinics. It operates through two products medical assistance and plans of dental care. The company was founded in 1979 and is headquartered in Fortaleza, Brazil.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HAPV3 is 2.71 BRL — it has decreased by −1.11% in the past 24 hours. Watch HAPVIDA ON NM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMFBOVESPA exchange HAPVIDA ON NM stocks are traded under the ticker HAPV3.
HAPV3 stock has fallen by −10.40% compared to the previous week, the month change is a −24.15% fall, over the last year HAPVIDA ON NM has showed a −38.13% decrease.
We've gathered analysts' opinions on HAPVIDA ON NM future price: according to them, HAPV3 price has a max estimate of 7.00 BRL and a min estimate of 5.00 BRL. Watch HAPV3 chart and read a more detailed HAPVIDA ON NM stock forecast: see what analysts think of HAPVIDA ON NM and suggest that you do with its stocks.
HAPV3 reached its all-time high on Jan 11, 2021 with the price of 18.43 BRL, and its all-time low was 1.93 BRL and was reached on Mar 9, 2023. View more price dynamics on HAPV3 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HAPV3 stock is 3.38% volatile and has beta coefficient of 1.09. Track HAPVIDA ON NM stock price on the chart and check out the list of the most volatile stocks — is HAPVIDA ON NM there?
Today HAPVIDA ON NM has the market capitalization of 20.01 B, it has decreased by −2.37% over the last week.
Yes, you can track HAPVIDA ON NM financials in yearly and quarterly reports right on TradingView.
HAPVIDA ON NM is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
HAPV3 earnings for the last quarter are 0.03 BRL per share, whereas the estimation was 0.05 BRL resulting in a −38.75% surprise. The estimated earnings for the next quarter are 0.07 BRL per share. See more details about HAPVIDA ON NM earnings.
HAPVIDA ON NM revenue for the last quarter amounts to 7.34 B BRL, despite the estimated figure of 7.33 B BRL. In the next quarter, revenue is expected to reach 7.51 B BRL.
HAPV3 net income for the last quarter is −81.26 M BRL, while the quarter before that showed −381.35 M BRL of net income which accounts for 78.69% change. Track more HAPVIDA ON NM financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HAPVIDA ON NM EBITDA is 2.13 B BRL, and current EBITDA margin is 10.60%. See more stats in HAPVIDA ON NM financial statements.
Like other stocks, HAPV3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HAPVIDA ON NM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HAPVIDA ON NM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HAPVIDA ON NM stock shows the sell signal. See more of HAPVIDA ON NM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.